ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$MLYS:NASDAQ · Mineralys Therapeutics Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 14.4544.99

Biopharma developing hypertension drug therapies

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 75. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy1,269,350$31,898,7660.0%
Paul Tudor Jones / Tudor61Trimmed -92%56,743$1,425,9520.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-03-31Shah Rajeev M.director369,000$8,762,797Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.